← TrialMatch
HomeTrials

The Outcomes of Living Donor Robotic Assisted Kidney Transplantation

The technology for robot-assisted kidney transplantation (RAKT) has become increasingly advanced, with numerous studies demonstrating comparable outcomes between RAKT surgery and open surgery. This advancement is particularly noteworthy as it extends its suitability to transplant patients with obesity. It will be impor

Condition(s)Kidney Transplant; Complications, Renal Failure Chronic
StatusRecruiting
Study typeObservational
SummaryThe technology for robot-assisted kidney transplantation (RAKT) has become increasingly advanced, with numerous studies demonstrating comparable outcomes between RAKT surgery and open surgery. This advancement is particularly noteworthy as it extends its suitability to transplant patients with obesity. It will be important to explore the results of robot-assisted kidney transplantation as compared with open surgery or within cohorts.
Who can participateInclusion Criteria: 1. living-donor kidney transplant recipients 2. receiving standard triad immunosuppressive regimen Exclusion Criteria: 1. active infection 2. multi-organ transplantation 3. malignancy history in the donor and recipient 4. human immunodeficiency virus infection
Ages18 Years to 65 Years
SexAll
Lead sponsorWest China Hospital
LocationsChengdu, Sichuan, China
Start date2020-07-01
NCT IDNCT06577805
Official listinghttps://clinicaltrials.gov/study/NCT06577805

🔍 Search all trials →